Preclinical Research
Preclinical Research
Strategies for Reducing the Number of Animals in Toxicity Testing: A Comparative Approach for Rodent and Large Animal Studies
Gene Therapy Utilizing Adeno-Associated Viral (AAV) Vectors: Historical Data Review to Characterize Common Challenges and Identify Opportunities for Refinement
Comparison of Toxicology Assessment Baseline Data Collected Using Two Restraint Methods in Nonhuman Primates: Restraint Chair/Pole and Collar vs. Procedure Cage
Downsized Sinclair™ vs. Göttingen™ Minipigs Similarities and Differences of Toxicological Reference Range Data in Preclinical Safety Studies
Ocular Imaging and Microscopic Analysis of Focal Chorioretinal Defects in Rabbits
Validation of an SC5b-9 Commercial Kit for Preclinical Biomarker Analysis
Correlating Changes in Body Weights and Immune System Parameters in Cynomolgus Macaques
ISSUE NO. 32 — A Changing Paradigm for Non-Rodent Species in Nonclinical Safety Studies
The choice of species for nonclinical safety studies is an important step in the drug development process. The species to be used is largely dependent on the test article type and clinical indication.
Scratching the Surface of Dermal Testing
Ophthalmic End-to-End Drug Development Solutions